COVID-19 necessitates urgent clinical and research action to properly address and manage its cardiovascular complications.
Absolute Event Rate: 0% vs 0%
sponsorship: This work is supported by COST (European Cooperation in Science and Technology) Action EU-CardioRNA CA17129. (COST (European Cooperation in Science and Technology) Action|EU-CardioRNA CA17129)
Emanueli et al. (Mon,) reported a other. COVID-19 necessitates urgent clinical and research action to properly address and manage its cardiovascular complications.